Literature DB >> 2810061

[Pharmacological studies on puerariae flos. I. The effects of puerariae flos on alcoholic metabolism and spontaneous movement in mice].

Y Niiho, T Yamazaki, Y Nakajima, H Itoh, T Takeshita, J Kinjo, T Nohara.   

Abstract

In the general rule, Puerariae Flos or it's combination drugs are used in traditional medicinal system for counteraction to drinking among Japanese and Chinese therapy. One of such drugs is Kakkakaiseito. Here we report the results of investigation on some pharmacological actions including alcoholic metabolism. The experiments were carried out to confirm its actual effect on alcohol, acetaldehyde and ketone body metabolism in the blood and the alteration of behaviour pattern of mice. Drugs used in this study were methanolic extract (PF-ME), isoflavonoid fraction (PF-IF) and triterpenoid saponin fraction (PF-SP) isolated from Puerariae Flos. Each drug was orally administrated to mice. These results were shown as follows: the concentrations of blood alcohol and acetaldehyde decreased more after the treatment with PF-IF (800 mg/kg) than those of the control group. This fact was evidenced remarkable effects with area under the blood concentration-time curve, mean residence time, and variance residence time and values on the moment analysis. However, a reduction effect was not recognized by the treatment with PF-SP (1000 mg/kg). Moreover, PF-ME and PF-IF suppressed the increment of spontaneous movement induced by alcohol administration, whereas PF-SP did not prevent the decrease in the increment caused by alcohol administration. These results support the basis that Puerariae Flos or its combination drugs is used in a traditional medicinal system for counteraction to drinking. However, further investigation is necessary.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2810061     DOI: 10.1248/yakushi1947.109.6_424

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


  6 in total

1.  Puerariae flos alleviates metabolic diseases in Western diet-loaded, spontaneously obese type 2 diabetic model mice.

Authors:  Koshi Kubo; Tsutomu Shimada; Rei Onishi; Masahito Tsubata; Tomoyasu Kamiya; Rika Nagamine; Seiichi Iizuka; Yoshimichi Sai; Sakae Amagaya; Masaki Aburada; Ken-ichi Miyamoto
Journal:  J Nat Med       Date:  2012-02-16       Impact factor: 2.343

2.  Simultaneous analysis of isoflavones and saponins in Pueraria flowers using HPLC coupled to an evaporative light scattering detector and isolation of a new isoflavone diglucoside.

Authors:  Yujiro Niiho; Yoshijiro Nakajima; Takashi Yamazaki; Mitsuru Okamoto; Ryota Tsuchihashi; Mitsuru Kodera; Junei Kinjo; Toshihiro Nohara
Journal:  J Nat Med       Date:  2010-03-31       Impact factor: 2.343

3.  Qualitative and quantitative evaluation of Flos Puerariae by using chemical fingerprint in combination with chemometrics method.

Authors:  Jing Han; Ke Xu; Quanxiang Yan; Wenwen Sui; Haotian Zhang; Sijie Wang; Zan Zhang; Ziyun Wei; Fei Han
Journal:  J Pharm Anal       Date:  2021-09-25

4.  The crude extract from puerariae flower exerts antiobesity and antifatty liver effects in high-fat diet-induced obese mice.

Authors:  Tomoyasu Kamiya; Mayu Sameshima-Kamiya; Rika Nagamine; Masahito Tsubata; Motoya Ikeguchi; Kinya Takagaki; Tsutomu Shimada; Masaki Aburada
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-27       Impact factor: 2.629

5.  Tectorigenin Attenuates Palmitate-Induced Endothelial Insulin Resistance via Targeting ROS-Associated Inflammation and IRS-1 Pathway.

Authors:  Qi Wang; Xiao-Lan Cheng; Dong-Yan Zhang; Xue-Jiao Gao; Ling Zhou; Xiao-Ying Qin; Guo-Yong Xie; Kang Liu; Yong Qin; Bao-Lin Liu; Min-Jian Qin
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

6.  Protective effects of total flavonoids from Flos Puerariae on retinal neuronal damage in diabetic mice.

Authors:  Dai Li; Fang Yang; Hongke Cheng; Chao Liu; Ming Sun; Kaili Wu; Ming Ai
Journal:  Mol Vis       Date:  2013-09-20       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.